Health News Worldwide

Promedior Announces Publication Of New Research Demonstrating Pentraxin-2/SAP Is A Potent Inhibitor Of Asthma And Asthma-Induced Lung Fibrosis

Allergy News - Thu, 09/09/2010 - 08:00
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced the publication of collaborative research in the Journal of Allergy and Clinical Immunology entitled, "Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore - induced allergic airway disease...
Categories: Allergies

Choice Of Career Is A Major Risk Factor For Persistent Neurodermatitis

Allergy News - Wed, 09/08/2010 - 09:00
A child who can't stop scratching himself may well be suffering from atopic dermatitis, also known as neurodermatitis. Extreme irritability of the skin with a concomitant urge to scratch is typical of the disorder. The condition often appears during the first year of life and is on the increase in industrialized countries...
Categories: Allergies

Epitwin: Largest Ever Epigenetics Project Launched

Allergy News - Tue, 09/07/2010 - 09:00
One of the most ambitious large-scale projects in Human Genetics has been launched: Epitwin will capture the subtle epigenetic signatures that mark the differences between 5,000 twins on a scale and depth never before attempted, providing key therapeutic targets for the development of drug treatments...
Categories: Allergies

EACAAI, Excellence In Clinical Education, Communication And Patient Care

Allergy News - Thu, 09/02/2010 - 10:00
Be among the first to hear the latest research from the world's leading allergists presented at the 2010 annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI), Nov. 11-16, in Phoenix...
Categories: Allergies

Shionogi Announces Positive Outcome To The Decentralized Procedure For The European Approval Of Twinject(R) (Epinephrine Auto-Injector)

Allergy News - Thu, 09/02/2010 - 07:00
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd...
Categories: Allergies

Microbiology Brought To Life In Nottingham, UK

Allergy News - Wed, 09/01/2010 - 12:00
Antimicrobial insect brains, mouth bacteria behaving badly and the hundreds of microbial communities that lurk in household dust are just some of the highlights at the Society for General Microbiology's autumn meeting in Nottingham next week. The annual event takes place on 6-9 September at the Jubilee Campus, University of Nottingham...
Categories: Allergies

In Cystic Fibrosis Patients, Vitamin D May Treat And Prevent Allergic Reaction To Mold

Allergy News - Sun, 08/29/2010 - 07:00
Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma, according to researchers from Children's Hospital of Pittsburgh of UPMC, the University of Pittsburgh School of Medicine and Louisiana State University School of Medicine. Results of the study, led by Jay Kolls, M.D., Ph.D...
Categories: Allergies

Man's Best Friend? Not During Hay Fever Season

Allergy News - Thu, 08/19/2010 - 09:00
Ragweed allergy season can be even more miserable for those with dog, cat or dust mite allergies, according to new research. These year-round allergies appear to "pre-prime" the immune system so symptoms hit harder, according to a study recently published in the Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI)...
Categories: Allergies

Allergists Offer Ragweed Survival Guide

Allergy News - Thu, 08/19/2010 - 08:00
August marks the start of misery for as many as one in five Americans who suffer from hay fever, also called seasonal allergic rhinitis. That's because ragweed, the main cause of hay fever, begins blooming around mid-August and in one day each plant can produce a million pollen grains that can travel for miles from its source...
Categories: Allergies

When Is Your Sneezin' Season?

Allergy News - Tue, 08/17/2010 - 11:00
If you spend August sneezing, ragweed may be your allergy enemy. If, like clockwork, you suffer in the spring, tree pollen may be to blame. And if your eyes itch and head feels stuffed up after the first frost should have killed every outdoor allergen, you may have indoor allergies...
Categories: Allergies

Vitamin D May Treat Or Prevent Allergy To Common Mold

Allergy News - Tue, 08/17/2010 - 11:00
Research conducted by Dr. Jay Kolls, Professor and Chair of Genetics at LSU Health Sciences Center New Orleans, and colleagues, has found that vitamin D may be an effective therapeutic agent to treat or prevent allergy to a common mold that can complicate asthma and frequently affects patients with Cystic Fibrosis...
Categories: Allergies

NICE Consults On Draft Guideline On Food Allergies In Children

Allergy News - Mon, 08/16/2010 - 12:00
NICE has opened the consultation on its draft clinical guideline on the diagnosis and assessment of food allergies in children and young people. Its aim is to support GPs and other health professionals in primary care and community settings in recognising the signs and symptoms of food allergy, by giving clear recommendations on taking allergy-focussed histories to assess the condition...
Categories: Allergies

Link Between Acetaminophen Use In Adolescents And Doubled Risk Of Asthma

Allergy News - Mon, 08/16/2010 - 07:00
New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with a 50 percent increase in the risk of asthma...
Categories: Allergies

Consortium Of Food Allergy Research Led By Mount Sinai Benefits From $29.9 Million Grant

Allergy News - Fri, 08/13/2010 - 10:00
Mount Sinai School of Medicine has announced that the National Institutes of Health (NIH) has renewed its funding of the Consortium of Food Allergy Research (CoFAR), providing an additional $29.9 million toward genetic research and the prevention and treatment of food allergy. Mount Sinai is the primary research site for CoFAR, leading seven other institutions around the country...
Categories: Allergies

South Bend Chocolate Company Announces Nationwide Recall Of Bountiful Blend Chocolates Due To Undeclared Tree Nuts

Allergy News - Wed, 08/11/2010 - 14:00
The South Bend Chocolate Company, South Bend, Indiana, is recalling 174 1-lb bags of Bountiful Blend, a blend of chocolate covered mixed nuts and dried fruits, because it contains undeclared cashews, almonds, pecans, and Brazil nuts...
Categories: Allergies

Allergy Shots Are Helpful For Some Asthmatics, Risky For Others

Allergy News - Mon, 08/09/2010 - 09:00
Allergy shots can reduce symptoms of asthma, use of inhaled medications and allergy-related asthma attacks, confirms an updated review of studies. Yet, the treatment can also cause systemic side effects that range from a stuffy nose to fatal anaphylactic shock...
Categories: Allergies

Chicago Mold Count Dangerously High

Allergy News - Mon, 08/09/2010 - 09:00
Chicago's mold count is 49,789 just a few spores away from the 50,000 threshold that signals a dangerous air quality warning. Today's mold count is the highest of the season, and the highest in five years. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr Joseph Leija, allergist at Loyola's Gottlieb Memorial Hospital. Dr...
Categories: Allergies

Transgenerational Genetic Effects - A Newly Discovered Mode Of Inheritance

Allergy News - Fri, 08/06/2010 - 09:00
The study of epigenetics has undoubtedly emerged as one of the hottest fields of research over the past decade. Interest in epigenetics has arisen as researchers endeavor to reveal the underlying causes of phenotypic variation and common diseases despite technological advances allowing for the characterisation of genetic variants and their heritability...
Categories: Allergies

Hayfever: Time We Moved Exams To The Winter?

Allergy News - Fri, 07/30/2010 - 09:00
Crucial exams take place during adolescence in most societies, which can have a major impact on an individual's career trajectory...
Categories: Allergies

Teva Respiratory Announces Positive Results From Phase III Trial Of BDP HFA Nasal Aerosol In Seasonal Allergic Rhinitis

Allergy News - Thu, 07/29/2010 - 09:00
Teva Respiratory announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo...
Categories: Allergies
Syndicate content

Alternative Therapies

Product Categories